Mkts

Rallybio Corporation

NASDAQ: RLYB
$16.38+0.10 (+0.61%)
As of Oct 19, 10:16 AM ET

Key statistics

Day range
16.2316.42
52-week range
3.6717.57
Today
Open16.41
Previous close16.38
Volume100
Valuation
Market cap86.45M
P/E ratio1.90×
EPS (TTM)7.89
Income & risk
Dividend / yield—
Beta-0.74
Avg volume25.4K
Discussion

RLYB News

Stories mentioning RLYB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue212.00222.00212.00212.00212.0038.00299.00299.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development2,8713,6554,1436,0745,7257,3858,24012,946
Sales General & Admin
Total Operating Expenses8,9456,6347,13710,2699,88211,64612,36517,334
Operating Income (Loss)(8,733)(6,412)(6,925)(10,057)(9,670)(11,608)(12,066)(17,035)
Interest Income
Interest Expense
Other Expense254.000.0022,479118.00174.00183.00251.00143.00
Pretax Income
Tax Provision
Net Income (Loss)(8,278)(5,852)16,016(9,703)(9,439)(11,044)(11,466)(16,236)
Earnings Per Share (Basic)(1.46)(1.04)0.36(0.22)(1.69)(2.03)(0.26)(0.37)
Earnings Per Share (Diluted)(1.46)(1.04)0.36(0.22)(1.69)(2.03)(0.26)(0.37)
Weighted Average Shares Outstanding (Basic)5,6895,62945,05944,8415,5985,44344,59344,128
Weighted Average Shares Outstanding (Diluted)5,6895,62945,05944,8415,5985,44344,59344,128

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RLYB

Rallybio Corporation (NASDAQ: RLYB) is a stock listed on the Nasdaq Stock Market under the ticker symbol RLYB. It last traded at $16.38 (Oct 19, 2026, 10:16 AM ET), up 0.6% on the day. That gives Rallybio a market capitalisation of $86.5M and a price-to-earnings ratio of 1.9.

Over the past 52 weeks RLYB has traded between $3.67 and $17.57.

Revenue for the quarter ended Mar 31, 2026 was $212.0K; a net loss of $8.3M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$212.0K-$8.3M-3904.7%
Dec 31, 2025$222.0K-$5.9M-2636.0%
Sep 30, 2025$212.0K$16.0M7554.7%
Jun 30, 2025$212.0K-$9.7M-4576.9%

From Rallybio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…